Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?
Jan 19
Have your own idea? Try our Stock Screener
Indian (NIFTY) Healthcare Sector Analysis
UpdatedJan 20, 2025
DataAggregated Company Financials
Companies286
- 7D-2.0%
- 3M-3.4%
- 1Y28.6%
- YTD-5.7%
Over the last 7 days, the Healthcare industry has dropped 2.0%, driven by a pullback from Max Healthcare Institute of 10%. On the other hand Biocon is actually up 9.1%. Over the past 12 months, the industry was up 29%. Earnings are forecast to grow by 19% annually.
Sector Valuation and Performance
Has the Indian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 20 Jan 2025 | ₹28.6t | ₹5.0t | ₹649.2b | 36.7x | 44.1x | 5.7x |
| Wed, 18 Dec 2024 | ₹28.9t | ₹5.0t | ₹644.3b | 37.7x | 44.9x | 5.8x |
| Fri, 15 Nov 2024 | ₹27.9t | ₹5.0t | ₹636.5b | 38.5x | 43.9x | 5.6x |
| Sun, 13 Oct 2024 | ₹29.5t | ₹4.9t | ₹605.3b | 43.2x | 48.8x | 6.1x |
| Tue, 10 Sep 2024 | ₹28.8t | ₹4.9t | ₹605.2b | 43.3x | 47.6x | 5.9x |
| Thu, 08 Aug 2024 | ₹27.1t | ₹4.8t | ₹578.8b | 37.6x | 46.8x | 5.6x |
| Sat, 06 Jul 2024 | ₹24.9t | ₹4.6t | ₹548.9b | 38.4x | 45.4x | 5.4x |
| Mon, 03 Jun 2024 | ₹22.9t | ₹4.7t | ₹548.3b | 33.1x | 41.7x | 4.9x |
| Wed, 01 May 2024 | ₹23.1t | ₹4.6t | ₹512.4b | 36x | 45x | 5x |
| Fri, 29 Mar 2024 | ₹22.8t | ₹4.6t | ₹512.7b | 33x | 44.5x | 5x |
| Sun, 25 Feb 2024 | ₹23.3t | ₹4.6t | ₹512.0b | 36.4x | 45.5x | 5.1x |
| Tue, 23 Jan 2024 | ₹21.3t | ₹4.4t | ₹477.8b | 37.1x | 44.6x | 4.8x |
| Thu, 21 Dec 2023 | ₹19.5t | ₹4.4t | ₹476.2b | 33.4x | 40.9x | 4.4x |
| Sat, 18 Nov 2023 | ₹19.1t | ₹4.4t | ₹476.0b | 32.8x | 40.1x | 4.3x |
| Mon, 16 Oct 2023 | ₹18.2t | ₹4.3t | ₹452.3b | 32.4x | 40.2x | 4.3x |
| Wed, 13 Sep 2023 | ₹18.0t | ₹4.2t | ₹450.8b | 31.4x | 40x | 4.2x |
| Fri, 11 Aug 2023 | ₹18.0t | ₹4.2t | ₹445.1b | 30.1x | 40.5x | 4.3x |
| Sun, 09 Jul 2023 | ₹16.5t | ₹4.1t | ₹425.6b | 28.5x | 38.7x | 4x |
| Tue, 06 Jun 2023 | ₹15.2t | ₹4.1t | ₹425.7b | 28x | 35.8x | 3.7x |
| Thu, 04 May 2023 | ₹14.0t | ₹3.9t | ₹372.8b | 28x | 37.5x | 3.6x |
| Sat, 01 Apr 2023 | ₹13.3t | ₹3.9t | ₹372.9b | 24.9x | 35.5x | 3.4x |
| Mon, 27 Feb 2023 | ₹13.3t | ₹3.9t | ₹373.6b | 25.3x | 35.6x | 3.4x |
| Wed, 25 Jan 2023 | ₹13.8t | ₹3.7t | ₹377.5b | 29x | 36.5x | 3.7x |
| Fri, 23 Dec 2022 | ₹14.2t | ₹3.7t | ₹377.3b | 28.5x | 37.5x | 3.8x |
| Sun, 20 Nov 2022 | ₹14.1t | ₹3.7t | ₹377.9b | 27.7x | 37.3x | 3.8x |
| Tue, 18 Oct 2022 | ₹13.8t | ₹3.6t | ₹360.0b | 25.5x | 38.4x | 3.9x |
| Thu, 15 Sep 2022 | ₹13.8t | ₹3.6t | ₹361.5b | 26x | 38.1x | 3.8x |
| Sat, 13 Aug 2022 | ₹13.7t | ₹3.6t | ₹366.0b | 23.2x | 37.3x | 3.8x |
| Mon, 11 Jul 2022 | ₹13.2t | ₹3.5t | ₹376.5b | 22.2x | 35.1x | 3.7x |
| Wed, 08 Jun 2022 | ₹13.0t | ₹3.5t | ₹375.5b | 22.8x | 34.5x | 3.7x |
| Fri, 06 May 2022 | ₹13.7t | ₹3.4t | ₹417.6b | 24.2x | 32.8x | 4x |
| Sun, 03 Apr 2022 | ₹14.2t | ₹3.4t | ₹420.2b | 25.4x | 33.9x | 4.1x |
| Tue, 01 Mar 2022 | ₹13.7t | ₹3.4t | ₹420.2b | 23.3x | 32.5x | 4x |
| Thu, 27 Jan 2022 | ₹14.2t | ₹3.4t | ₹437.9b | 25.7x | 32.4x | 4.2x |
Price to Earnings Ratio
32.4x
Current Industry PE
- Investors are optimistic on the Indian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 44.1x which is higher than its 3-year average PE of 39.8x.
- The 3-year average PS ratio of 4.4x is lower than the industry's current PS ratio of 5.7x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 14% per year over the last three years.
- Revenues for these companies have grown 14% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare sector?
| IN Market | -0.26% | |
| Healthcare | -1.99% | |
| Biotech | 7.78% | |
| Life Sciences | 1.08% | |
| Pharma | -1.75% | |
| Healthtech | -2.21% | |
| Healthcare Services | -5.18% | |
| Medical Equipment | -5.43% | |
Industry PE
- Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 20.8x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Biotech industry, which is trading below its 3-year average of 40.7x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 27% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Biotech industry is expected to see its earnings grow by 5.8% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹393.70 | 9.1% +₹39.2b | 43.7% | PE32.7x | |
| DIVISLAB Divi's Laboratories | ₹5.92k | 2.5% +₹38.4b | 62.1% | PE85.5x | |
| PPLPHARMA Piramal Pharma | ₹230.70 | 4.3% +₹12.5b | 60.7% | PE674.7x | |
| GLS Alivus Life Sciences | ₹1.08k | 7.2% +₹9.0b | 35.8% | PE31.4x | |
| INDGN Indegene | ₹651.45 | 5.9% +₹8.7b | n/a | PE41.8x |
